Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%)
< Home < Back

Natco Pharma to consider Interim Dividend

Date: 30-01-2012

Natco Pharma has informed that a meeting of the board of directors of the company will be held on February 09, 2012, to consider the unaudited financial results for the quarter ended December 31, 2011, to consider Interim Dividend, if any, for the financial year 2011-12 and related matters.

The above information is part of company’s filing submitted to the BSE.